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Between 15 and 40% of cancer patients develop clinical anxiety
and/or depression (Derogatis et al, 1983; Massie and Holland,
1990; Parle et al, 1996). Even for those ostensibly cured the preva-
lence remains appreciably higher than that of the general popula-
tion a year or more after diagnosis (Devlen et al, 1987). This
evidence, combined with significant pressure from service users,
has led to increasing provision of psychological interventions in
British oncology services. This has been piecemeal (Fallowfield,
1988) and guided more by local factors than evidence of efficacy.
There is little evidence based consensus about optimal methods of
intervention, appropriate standards for clinical practice and
training, or whether service provision is best directed towards
prevention or the treatment of disorder (Fallowfield and Roberts,
1992; Hopwood and Maguire, 1992; Brennan and Sheard, 1994).
The impact of psychological interventions in oncology on
psychosocial, disease, symptom and treatment side-effect
outcomes has been evaluated in a relatively large number of trials
which vary considerably in their research questions, methodology,
settings and results. Meyer and Mark (1995) aggregated all
psychological outcomes for 45 such trials and reported a small
mean effect size of 0.24 standard deviations for a single aggregate
measure of psychological outcome. Their broad entry criteria
ensured the inclusion of a large number of trials but the resulting
extreme heterogeneity in terms of diversity of research questions
and outcome measures render the meaning of this aggregate
finding difficult to assess. We conducted, therefore, two meta-
analyses of trials of interventions which sought to treat or prevent
anxiety and/or depression. The relevance of the findings to clinical
practice and service provision is assessed.
METHODS
Identical methods were used for the two meta-analyses
Search strategy
Medline, PsycLit and BIDS social sciences computerized data-
bases were searched using the using the keywords cancer,
counselling, psychotherapy, psychological therapy, group
support/therapy, relaxation, imagery and visualization. Citations in
identified papers and reviews (Watson, 1983; Cunningham, 1988;
Vachon, 1988; Harman, 1991; Andersen, 1992; Trijsburg et al,
1992), Aslib. index to theses (keywords cancer, counselling and
psychotherapy), and Comprehensive Dissertation Abstracts:
Psychology (keyword cancer) were manually searched.
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Inclusion and exclusion criteria
Trials were included if they (a) evaluated psychosocial or psychi-
atric interventions aimed specifically at alleviating psychological
distress in oncology subjects, (but excluded if the main focus was
the reduction of physical symptoms, prolongation of survival,
impact on immune parameters or reduction of peri-surgical
distress); (b) had a control condition; and (c) had been published in
a journal or indexed as a dissertation before January 1993 when
this project was initiated. Resource constraints limited inclusion of
trials to those available in an English language form through
British library services.
Single group designs (i.e. those without a control group) were
excluded. Restricting eligibility to randomized control trials was
considered but at present evidence from psychotherapy meta-
analyses suggests that randomization does not affect outcome.
Lipsey and Wilson (1993) in their meta-analysis of 136 meta-
analyses of psychological interventions identified only three
factors which significantly influenced size of effect: single group
designs (i.e. those with no control group) and small sample size
trials had larger effects (publication bias), while placebo-
controlled trials had smaller effects. The possible influence of
different aspects of trial quality on our meta-analyses are explored
in a sensitivity analysis. Excluding non-randomized trials would
also have the disadvantage of reducing the representativeness of
the sample and the statistical power.
Coding
Data from published and unpublished reports were entered on a
standardized coding form which included criteria for assessing and
coding ambiguous information. Study features were coded under
specific domains: independent variable (e.g. type of therapy,
‘dose’ of therapy), subject (e.g. prognosis) and setting variables,
experimental method, dependent variables (i.e. anxiety and
depression), and quality of reporting. A system for scoring aspects
of study methodology was devised based on Cook and Campbell’s
(1979) four categories of threats to validity (available on request).
Studies which used more reliable methods were identified using
three factors: (i) use of randomization, (ii) falling into the top 75%
on overall quality score, and (iii) sample size greater than 40.
Results were coded for ‘post-tests’ (outcomes measured imme-
diately after completing the intervention) when performed, or for
observations taken between 3 and 6 months after commencement
of flexible length interventions.
Outcome measures
For those trials using more than one anxiety or depression measure
the result from only one instrument was selected to represent each
domain. Commonly used measures were selected preferentially to
increase comparability. Failing this, the data from the instrument
with superior psychometric properties were included, or if this was
similar, selection was random.
Statistical methods
Effect sizes for continuous psychological data are normally repre-
sented in terms of standard deviation shift; thus a positive value
represents a better outcome for the intervention group. Where
possible the effect size ‘g’ was estimated as a standardized mean
difference: this is the mean value for the intervention group minus
mean value for control group divided by their pooled standard
deviation. For studies not providing this data ‘g’ was estimated
from precise statistical test values (Hedges and Olkin, 1985).
Hedges and Olkin (1985) have shown that ‘g’ has a small sample
bias, this is corrected into the unbiased estimator ‘d’ which is very
similar to ‘g’ for large studies but smaller in small studies.
Confidence intervals for the effect sizes of individual studies were
based on estimates of conditional variance as given by Hedges and
Olkin (1995). Prof R Schwarzer’s meta-analysis programme was
used (Frei Universitat Berlin, Germany).
In view of the broad entry criteria, descriptive focus and an
expectation of considerable heterogeneity the more conservative
random effects analysis was used (Cook and Campbell, 1979;
Raudenbush, 1994) both in estimation of main effects and in
exploration of the moderating effect of variables which were
hypothesized to affect outcome (such as the amount of therapy
given, the therapists’ level of training and experience, or cancer
prognosis). Fixed and random effects models address the problem
of heterogeneity in different ways and have complementary
strengths and shortcomings (Cook and Campbell, 1979;
Thompson, 1993). Estimates of the main effects obtained using
these models are compared in a sensitivity analysis.
Tests for interaction were used to see whether there was
evidence of different size of effect in two or more groups. This was
achieved by subtracting the sum of Q’s (homogeneity statistics)
for individual groups from the Q for the individual groups
combined. This yields a c2 value with n21 degrees of freedom
where n is the number of groups.
Publication bias (the tendency for only studies with statistically
significant results to be accepted for publication) presents a
considerable threat to the representativeness of meta-analysis
samples. This was estimated using three methods. The effect sizes
for published and unpublished studies were compared, a smaller
mean effect size for unpublished studies would be an indicator of
publication bias. Funnel plots of sample size against effect size
indicate if small sample size trials are inadequately represented
Table 1 Trials used in the meta-analyses
Anxiety meta-analysis only
Carpenter, 1984
Cumbia, 1985
Davis, 1986
Golonka, 1976
Johnson, 1982
Depression meta-analysis only
Guerrant, 1984
Hayes, 1981
Linn et al, 1982
Price, 1982
West, 1980
Youssef, 1984
Anxiety and depression meta-analyses
Bindemann et al, 1991
Bloom et al, 1978
Cain et al, 1986
Christensen, 1983
Decker et al, 1992
Fawzy et al, 1990
Frankel, 1985
Greer et al, 1992
Houts et al, 1986
Hurst, 1986
Maguire et al, 1980
Spiegel et al, 1981
Telch and Telch, 1986
Worden and Weisman, 19841772 T Sheard and P Maguire
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while Rosenthal’s (1979) ‘fail safe n’ indicates the number of
unpublished studies of effect size zero locked away in researchers’
filing cabinets which would be required to reduce the mean effect
size to a specific level.
For those studies comparing two different interventions with a
common control group the intervention groups’ effect sizes are not
independent and therefore the data for the less structured interven-
tion arms were eliminated (e.g. in a comparison of a coping skills
intervention with simple support the support arm was eliminated
(Telch and Telch, 1986)).
RESULTS
Anxiety was used as an outcome measure in 19 studies, depression
in 20 and 14 studies were common to the two meta-analyses
(Table 1). Five trials (Worden and Weisman, 1984; Cumbia, 1985;
Cain et al, 1986; Davis, 1986; Telch and Telch, 1986) compared
two types of intervention with a common control. Only three
studies (Maguire et al, 1980; Bindemann et al, 1991; Greer et al,
1992), all of individual therapy, were conducted outside of the US,
many were conducted in university hospitals and the samples were
generally skewed towards whites, the well-educated, women and a
diagnosis of breast cancer. Inclusion criteria were largely medical
rather than psychological. The majority of trials were preventative
in orientation: only three anxiety (Worden and Weisman, 1984;
Telch and Telch, 1986; Greer et al, 1992) and four depression trials
(West, 1980; Worden and Weisman, 1984; Telch and Telch, 1986;
Greer et al, 1992) restricted inclusion to those identified as being at
risk of, or suffering, significant psychological distress. In other
trials subjects were recruited sequentially on the basis of a cancer
diagnosis, or on referral by an oncologist, or were self-selected.
The analyses of the anxiety and depression data are presented
separately. Table 1 lists the references included in the anxiety
and/or depression meta-analyses.
Anxiety meta-analysis
Nineteen trials were included (Table 1). A total of 26 trials were
identified measuring anxiety and met initial entry criteria, but six
were excluded as effect sizes could not be estimated (Table 2).
Figure 1 shows the spread and confidence intervals for the 19
studies. The total sample size is 1023, the combined effect size is
0.42 and the dataset is strongly heterogeneous. Nine trials used the
Profile of Mood States (POMS) (McNair et al, 1971) tension
subscale as a measure of anxiety, five used the Spielberger State
Anxiety Inventory (Spielberger et al, 1983), and the remaining five
used other measures.
Sensitivity Analysis (Table 2 and Figure 2)
Table 2 summarizes trials excluded from both meta-analyses. It
was possible in some cases to gain an indication of the magnitude
Table 2 Exclusions
Author Origin Year Intervention Intervention Sample size Anxiety: Depression:
type mode (one Estimated Estimated
experimental effect of effect of
group inclusion inclusion on
and on mean mean effect
controls) effect size size
Farash USA 1977 Brief Individual 40 Not Deflate
(Thesis) therapy measured
Gordon USA 1980 Education Individual 308 Deflate Deflate
and
counselling
Capone USA 1980 Crisis Individual 97 * *
intervention
Fairbanks USA 1981 Simonton and Group 24 Not Not
(Thesis) Rational measured evaluable
emotive
therapy
Heinrich USA 1985 Psychoeducational Group 70 * *
course
Watson UK 1988 Information Individual 28 Very little Inflate
(M) /expression effect
of emotion
Bridge UK 1988 Relaxation Individual 92 Deflate Deflate
and imagery
Burton UK 1988 Rogerian: Individual 42 No effect Deflate
single
session
Clacey UK 1988 Information Individual 25 Probably Probably
and little or no little or no
counselling effect effect
Halttunen Finland 1992 Focus on Group 65 Not Not
appraisal measured evaluable
and coping
A very approximate estimate of effect size was obtained by (a) calculating effect sizes from data from selectively presented outcomes and adjusting this down
according to the extent of incompletely reported data for other outcomes, (b) noting when outcomes hardly differed between treatment and control groups, (c)
assuming small effect sizes in trials which had statistically non-significant results despite a large sample. *Low scores for distress at baseline and follow-up in
treatment and control groups and therefore treatment effect not demonstrable.Anxiety and depression in cancer patients 1773
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of effect in the excluded studies. Inclusion of two (Gordon et al,
1980; Bridge et al, 1988) might have reduced the mean effect size
for anxiety (see second last column Table 2).
Two extreme positive outliers stand out in Figure 1 (Johnson,
1982; Telch and Telch, 1986) and have a combined sample size of
79. Removal of these reduces the effect size by a third to 0.27
(Figure 2).
There are indications that the use of randomization and other
features contributing to greater reliability in design are associated
with larger effects (Figure 2). Fifteen studies used randomization
to determine allocation to condition and these have a greater
combined effect size than the four non-randomized studies (0.5
vs 0.19). Eight studies met our criteria for greater reliability and
these have a greater mean effect size than the 11 studies of less
reliable design (0.63 vs 0.24). This difference is not attributable
to the two extreme positive outliers as one fell into each group.
Removing the one positive outlier (effect size 2.6, sample size
52) (Johnson, 1982) from the group of 11 trials of more reliable
design reduces the effect size by nearly 50% to 0.36 (95% CI
0.095–0.63).
Author &
Year
Golonka (T)
Bloom
Maguire
Spiegel
Johnson
Christen.
Carpent.(T)
Worden
Cumbia (T)
Frankel (T)
Cain
Davis
Houts
Hurst (T)
Telch
Fawzy
Bindem.
Decker
Greer
1976
1978
1980
1981
1982
1983
1984
1984
1985
1985
1986
1986
1986
1986
1986
1990
1991
1992
1992
Treatment
mode
Group
Individ
Individ
Group
Group
Couple
Group
Individ
Group
Group
Individ
Individ
Individ
Group
Group
Group
Relax
Relax
Individ
n*
38
39
152
30
52
20
22
117
12
24
72
12
32
23
27
66
71
63
151
R
–
–
+
+
+
+
+
–
+
+
+
+
–
+
+
+
+
+
+
Total 1023
(T) = Unpublished thesis
R = Randomized assignment
* For trials with more than one intervention group (Cain, Davis and Telch)
sample size is the number in the included experimental group plus the
number in the control group
– 2 – 1 01234
Effect size (95% confidence intervals)
(vertical solid line indicates zero and dotted line the mean effect size)
Mean effect size is 0.42 (95% CI 0.08–0.74)
Strongly Heterogenous: Q= 69.2175, P < 0.00000
Published
Unpublished
More reliable design
Less reliable design
Two extreme positive
outliers removed
Fixed effects analysis
Random effects
analysis
n*
14
5
8
11
17
19
19
ES**
0.51
0.16
0.63
0.24
0.27
0.36
0.42
–1.0 0.0 1.0 2.0
Effect size and 95% confidence intervals
LCI
n ES
UCI
* n = Number of trials
**ES = Effect size (All random effects analysis with exception of fixed effects statistic). Vertical line is zero
exception of fixed effects statistic) Vertical line is zero
Figure 1 Effect sizes and 95% confidence intervals for individual studies: anxiety
Figure 2 Sensitivity analysis: anxiety1774 T Sheard and P Maguire
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The data from this sample suggest bias in the published sub-
sample: published studies (n = 14) have a mean effect size of 0.51,
compared to 0.16 for unpublished theses (n = 5). However,
including the unpublished theses in a funnel plot results in a
reasonably symmetrical distribution. Applying Rosenthal’s ‘fail
safe n’ indicates that 20 undetected studies of effect size zero are
required to reduce the effect size to 0.2 (0.2 is a level generally
regarded as representing a clinically weak to negligible effect for
psychological interventions).
The larger effect size found using the usually more conservative
random effects compared to the fixed effects analysis is difficult to
explain as a correction is made for small sample size bias. Wider
confidence intervals are expected for the random effects analysis
as they include estimates both of between and within study
sampling variation.
Variables influencing effects (Figures 3 and 4)
The marked heterogeneity of the data supported a preliminary
n1 ES2 P3
Individual therapy 8 0.27
Relaxation 2 0.21 0.0076
df = 2
Group therapy 9 0.69
Group therapy excluding 6 0.27 0.0005
psycho-education df = 1
Group psycho-education 3 1.59
All studies: Anxiety 19 0.42 0.0000
– 1 01234
Effect size and 95% confidence intervals
Vertical line represents mean effect size
1n = Number of trials
2ES = Effect size (random effects analysis)
3P = P value for heterogeneity test between variables (random effects analysis)
Figure 3 Treatment type: anxiety
n1 ES2 P3
<4 hours therapy 4 0.21
4–7 hours therapy 6 0.41 0.0017
8+ hours therapy 4 1.01 df=2
Less experienced therapist 4 0.10
More experienced therapist 6 0.57 0.0540
Advanced disease 3 0.46
Good or mixed 13 0.4 0.28
prognosis
Screened 3 0.85
Not screened 5 0.33 0.1715
All studies anxiety 19 0.42 0.0000
Effect size and 95% confidence intervals
Vertical line represents mean effect size (random effects analysis)
1n = Number of trials
2ES = Effect size (random effects analysis)
3P = P value for heterogeneity test between variables
– 1 01234
Figure 4 Dose, therapist and subject variables: anxietyAnxiety and depression in cancer patients 1775
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exploration of the possible moderating effect of clinically relevant
variables. This was done using hypotheses formed before begin-
ning the data analysis. Contrary to prediction interventions
delivered in an individual format had an effect size similar to
relaxation alone and only approximately 50% that of interventions
in a group format (P = 0.0076). Three trials of groups psycho-
educational courses (Johnson, 1982; Telch and Telch, 1986;
Fawzy et al, 1996) had a considerably larger mean effect than
other group interventions (P = 0.0005). This subgroup almost
entirely accounts for the difference in effect size between group
and individual interventions (Figure 3); it also contains both of the
positive outliers. Further analysis of the influence of type of
therapy on effect size could have been of considerable clinical and
theoretical interest but was precluded by the great diversity of
types of intervention.
The findings for other variables which might influence effect
– 2 – 1 0123
Author & Treatment n*R
Year mode
Bloom 1978 Individ 39 –
Maguire 1980 Individ 152 +
West (T) 1980 Individ 14 +
Hayes (T) 1981 Group 12 –
Spiegel 1981 Group 30 +
Linn 1982 Individ 92 +
Price (T) 1982 Group 44 –
Christensen 1983 Couple 20 +
Youssef 1983 Group 18 –
Guerra. (T) 1984 Group 34 +
Worden 1984 Individ 117 –
Frankel (T) 1985 Group 24 +
Cain 1986 Individ 72 +
Houts 1986 Individ 32 –
Hurst (T) 1986 Group 23 +
Telch 1986 Group 27 +
Fawzy 1990 Group 66 +
Bindemann 1991 Relax 71 +
Decker 1992 Relax 63 +
Greer 1992 Individ 151 +
Total 1101
(T) = Unpublished thesis
R = Randomized assignment
* For trials with more than one intervention group (Cain, Davis and Telch)
sample size is the number in the included experimental group plus the
number in the control group
Effect size (95% confidence intervals)
(vertical solid line indicates zero and dotted line the mean effect size)
Mean effect size is 0.36 (95% CI 0.08–0.66)
Heterogenous: Q= 40.6467, P < 0.0027
Figure 5 Effect sizes and 95% confidence intervals for individual studies: depression
Published
Unpublished
More reliable design
Less reliable design
Two extreme positive
outliers removed
Fixed effects analysis
Random effects
analysis
n*
14
5**
8
12
17
20
20
ES***
0.34
0.27
0.21
0.50
0.19
0.25
0.36
–1.0 0.0 1.0 2.0
Effect size and 95% confidence intervals
LCI
ES
UCI
* n = Number of trials
** Excluding one extreme outlier (West)
*** ES = Effect size (All random effects analysis with
exception of fixed effects statistic) Vertical line is zero
Figure 6 Sensitivity analysis: depression1776 T Sheard and P Maguire
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(Figure 4) must be viewed with considerable caution as they are
based only on those studies, on occasion a small minority, which
actually specified them and therefore cannot be taken as represen-
tative of the sample. The data suggest a dose–response effect
(P = 0.0017) which is unlikely to be due to a maturation confound
as interventions given over a 6-week or shorter period actually
have a marginally greater effect size (0.6) than those taking longer
than 6 weeks (0.52). The use of more experienced therapists is
associated with a larger effect but this falls just below the 5% level
(P = 0.054). Effects were preserved at follow-up in the small
minority (n = 4) of trials which examined this important outcome
at a variety of time points beyond the end of the intervention (Cain
n1 ES2 P3
Individual therapy 9 0.30
Relaxation 2 0.03 0.1097
Group therapy 9 0.54
Group therapy excluding 7 0.42
psycho-education 0.5376
Group psycho-education 2 0.94
All studies: Depression 20 0.36 0.0027
– 1 0123
Effect size and 95% confidence intervals
Vertical line represents mean effect size (random effects analysis)
1n = Number of trials
2ES = Effect size (random effects analysis)
3P = P value for heterogeneity test
Figure 7 Treatment type: depression
n1 ES2 P3
<4 hours therapy 3 0.08
4–7 hours therapy 6 0.29 0.4311
8+ hours therapy 2 0.32 df=2
Less experienced therapist 2 –0.18
More experienced therapist 7 0.43 0.0375
Advanced disease 5 0.64
Good or mixed 12 0.24 0.0327
prognosis
Screened 4 0.94
Not screened 5 0.16 0.1594
All studies: Depression 20 0.36 0.0027
Effect size and 95% confidence intervals
Vertical line represents mean effect size (random effects analysis)
1n = Number of trials
2ES = Effect size (random effects analysis)
3P = P value for heterogeneity test between variables
– 1 01234
Figure 8 Dose, therapist and subject variables: depressionAnxiety and depression in cancer patients 1777
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et al, 1986; Davis, 1986; Fawzy et al, 1990; Greer et al,
1992).
Unfortunately there was insufficient data available to explore
the potentially important influence of the timing of the commence-
ment of interventions relative to diagnosis, relapse and treatment.
Depression meta-analysis
Twenty trials were included (see Table 1). A total of 30 trials were
identified which measured depression and met initial entry
criteria, but ten were excluded as effect sizes could not be
estimated (Table 2). Figure 5 shows the spread and confidence
intervals for the 20 trials. The total sample size is 1101, the
combined effect size is 0.36 and the dataset is strongly hetero-
geneous. Twelve depression effect sizes were measured using the
Profile of Mood States (POMS) depression subscale (McNair et al,
1971), five using the Beck Depression Inventory (Beck and Steer,
1987) and three used other measures.
Sensitivity analysis (Table 2 and Figure 6)
The ten excluded studies are summarized in Table 2. Inclusion of
four (Farash, 1977; Gordon et al, 1980; Bridge et al, 1988; Burton
and Parker, 1988) would probably have reduced the mean effect
size, while inclusion of one (Watson et al, 1988) would have
increased it.
Removal of three positive outliers (West, 1980; Youssef, 1984;
Telch and Telch, 1986) with a total sample size of 59 reduces the
overall effect by a half to 0.19 (Figure 6).
The use of randomization did not appear to influence effect: the
14 randomized trials have a very similar combined effect size to
the six non-randomized trials (0.38 vs 0.31). Superior study
quality appears to be associated with weaker effects (Figure 2):
eight studies meeting the criteria for more reliable design have a
smaller mean effect size than 12 less reliable studies (0.21 vs
0.50). However, this difference is entirely attributable to the three
positive outliers falling into the unreliable design group. Their
elimination reduces the combined effect size for this group to 0.18,
equivalent to the 0.21 value for the more reliable studies.
Publication bias does not appear to be a feature of the published
subsample as these trials have very similar mean effect sizes to the
unpublished trials even with one unpublished small sample size
extreme positive outlier (West, 1980) removed. A funnel plot does
not show a skewed distribution. Sixteen unpublished studies with
an effect size of zero hidden in researchers’ filing cabinets are
required to reduce the mean effect size to 0.2.
Variables influencing effects (Figures 7 and 8)
The marked heterogeneity of the data supported a preliminary
exploration of the possible moderating effect of clinically relevant
variables. As for the anxiety data-set individual interventions have
a smaller effect size than group interventions but for depression
this difference is not statistically significant. The two trials of
relaxation have an aggregate effect size of zero, one had a positive
effect (Bindemann et al, 1991), one a negative effect (Decker et al,
1992).
Again the findings for other variables which might influence
effect must be viewed with considerable caution as they represent
data only from those studies which actually specified them. As for
anxiety a larger effect size is associated with higher therapist level
of training and experience in oncology (P = 0.0375 with one very
small sample size extreme outlier removed (West, 1980)). Effect
size is greater for those with advanced disease (P = 0.0327). Only
three trials included follow-up measures (Halttunen et al, 1992),
mean effect at post-test (0.27) was at least sustained at follow-up
(0.49).
DISCUSSION
As expected the included trials show considerable variation in
subjects, settings, intervention modality, theoretical base, therapist
expertise, amount of therapy given and experimental methods.
This clinical marked heterogeneity suggests that the emphasis in
these meta-analyses should be on the main effects, in particular
their clinical significance and robustness.
The anxiety main effect of 0.42 can be taken to be fairly robust.
Publication bias in the published sub-sample appears to have been
corrected by inclusion of unpublished theses which had smaller
effects and sample sizes. Twenty unpublished trials of zero effect
size would be required to produce a 50% reduction in effect size.
Inclusion of the seven studies which were excluded because of
missing data would most probably have had very little impact on
the combined effect size. The main threat to robustness appears to
be the large influence of two positive outliers with a combined
sample size of 79. Removing them renders the overall effect much
smaller and of marginal clinical significance. However, trials with
more reliable design have a moderate to strong effect size of 0.63.
Only one of the extreme positive outliers falls into this group and
its removal reduces the effect size down to 0.36; this is comparable
with, but slightly less than the overall effect size of 0.42 for all 19
anxiety studies. This value of 0.36, based on the ten of the 19 trials
of most reliable design, can be taken to be the most robust
summary statistic for the anxiety trials.
Normative data for the Spielberger State Anxiety Inventory
(STAI), which was used in five of the 19 trials, give some indica-
tion of the clinical significance of these anxiety effect sizes. A 0.36
standard deviation shift for the STAI is approximately equivalent
to the difference between the anxiety levels of normal subjects and
that of general medical and surgical in-patients (Spielberger et al,
1983).
The depression main effect of 0.36 is not as robust as that for
anxiety: there is no evidence of publication bias but including only
those trials with more reliable design decreases it by nearly 50% to
0.21. Similarly, eliminating the three extreme positive outliers
(which all fall into the less reliable design subgroup) reduces the
mean effect to 0.19. Also inclusion of the trials excluded through
missing data (Table 2) would also probably reduce the mean
effect. The Beck Depression Inventory (BDI) was used in five of
the 20 depression trials; for the BDI a 0.36 standard deviation shift
approximates to 50% (and 0.21 standard deviation to 30%) of the
difference between the means of moderate and mild depression
(Beck et al, 1961), but a 0.21, or 0.19 shift is little more than half
of this and of very doubtful clinical significance. In summary, the
main effect for anxiety can be taken to be of moderate clinical
significance, that for depression as weak to negligible.
The clinically significant effect for anxiety but not depression
may in part be attributable to the well-established finding that the
prevalence of anxiety in oncology populations is greater than that
for depression (Parle et al, 1996). Prevalence is relevant in this
case as the great majority of both the anxiety and depression trials
in this sample were preventative in nature, i.e. the subjects were
not selected on psychological criteria. This preventative orienta-
tion is a very important feature of the trials included in these two1778 T Sheard and P Maguire
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meta-analyses; the majority of trials recruited subjects on the basis
of a diagnosis of cancer, or being thought suitable for inclusion by
an oncologist, or being self-referred. Consequently, a large propor-
tion of the individuals receiving an intervention may have neither
needed nor benefited from it. This would substantially reduce
effect size and indeed the mean effect even for anxiety is only
about 50% of the mean effect of 0.69 found in a meta-analysis of
trials of psychotherapy for depression (Robinson et al, 1990) (not
cancer patients). However, the anxiety effect is not a great deal
smaller than the overall mean of 0.5 found by Lipsey and Wilson
(1993) in their meta-analysis of meta-analyses of psychological
interventions in many settings. Also four meta-analyses of antide-
pressants for depression have reported effect sizes between 0.19
and 0.79 (Smith et al, 1980; Shapiro and Shapiro, 1982; Quality
Assurance Project, 1983; Steinbrueck et al, 1983; Greenberg et al,
1992).
Unfortunately, only four trials specifically recruited subjects
identified as either suffering from, or at high risk of, significant
psychological distress (Linn et al, 1982; Worden and Weisman,
1984; Telch and Telch 1986; Greer et al, 1992). The effect sizes for
screened subjects are large and similar for anxiety (0.94, n = 3) and
depression (0.85, n = 4). For non-screened subjects the anxiety
effect size is moderate to weak (0.33) but again the depression
effect size is small and clinically insignificant (0.16) (Figure 4 and
8). These differences are not statisticaly significant at the 5% level,
but the statistical power is low. More data is needed on the effec-
tiveness of psychological interventions with cancer patients who
are identified as either suffering from, or at risk of significant
psychological distress.
The effect size for the anxiety meta-analysis is appreciably
greater than that of 0.24 found by Meyer and Mark (1995) in their
less focused fixed effects meta-analysis of 45 published trials of
psychological interventions in oncology. Their sample included a
wide range of psychological, educational or nursing interventions
aimed at altering an extremely broad range of outcomes which
included pain or treatment side-effects, psychological distress,
identified problems and quality of life. The effect size of 0.24 was
an average of any psychological outcome measures made in this
disparate set of trials. We compared our samples with theirs:
Meyer and Mark (1995) included only 11 of our 16 published trials
(and by definition none of our nine unpublished trials), and only
one (80) of our ten trials (two unpublished) excluded because of
missing data. They did not appear to have identified any trials
unknown to us. Meyer and Mark’s findings are therefore based on
a sample which is 75% different from ours, less focused in terms
of trial aims and outcomes, and which appears to be less represen-
tative of the literature. Most of the difference in findings could be
attributed to these factors.
Examination of extreme outliers is important as they may repre-
sent an important subset with particular features in common which
account for their distance from the mean. For anxiety there are two
obvious positive outliers which are both trials of group psycho-
educational courses (Johnson, 1982; Telch and Telch, 1986). This
type of intervention has a large mean effect size of 1.59 (n = 3
trials, total sample size 145) compared with 0.27 found for other
group interventions. There was no obvious pattern to the three
depression-positive outliers which consisted of trials of group
therapy (Capone et al, 1980), of a group psycho-educational
course (69) and individual cognitive therapy (Linn et al, 1982).
There were no obvious negative outliers, but six anxiety and three
depression trials did have negative effect sizes. This statistical
variation is expected but the majority of these trials also had
features which made a negative finding more likely.1
Interaction effects
Exploration of the effect of therapy type produced unexpected
findings (Figures 3 and 7). The large effects found for the few
trials of group psycho-educational courses for both anxiety and
depression are impressive but require replication. The equivalent
effect of group and individual therapy (after subtraction of group
psycho-educational courses) was contrary to prediction
and contrasts with Shapiro and Shapiro’s meta-analysis of
psychotherapy which found individual therapy to be more effec-
tive than group (Shapiro and Shapiro, 1982). This unusual finding
could be a reflection of cancer patients having a shared predica-
ment. The data on relaxation are sparse but as predicted there was
an effect on anxiety but not depression. The influence of other
hypothesized moderator variables is only suggestive and is
presented (Figures 4 and 8) mainly as a potential basis for hypoth-
esis generation for future trials or explanatory meta-analyses. The
numbers of studies in some subgroups are extremely small but the
results are strengthened by their being very largely in the expected
direction.
The findings have considerable clinical and service implica-
tions:
i. These data can help inform the problem of where best to direct
limited clinical resources. The results indicate that preventa-
tive routine psychological intervention for all cancer patients
will at best have a clinically moderate effect on anxiety, but a
negligible one on depression. Resources are scarce and there-
fore it is likely that clinically powerful and therefore cost-
effective outcomes for anxiety and depression are only likely
to result in interventions targeted at those suffering from or at
risk of significant psychological distress. However, only four
out of the 25 trials in the two meta-analyses intervened specifi-
cally on such patients. More trials of this kind are needed to
establish whether they reliably result in clinically strong
effects.
ii. Group therapy appears equally effective to individual, or
perhaps considerably more so in the case of group psycho-
educational courses. Group therapy is clearly cheaper to
provide but the group therapy data are exclusively North
American and therefore replication in the very different
European cultural and health service context is required.
iii.There is evidence to suggest that relatively short but intensive
interventions delivered by experienced and more highly
trained therapists are more effective than more protracted
interventions offered by less psychologically trained staff. It is
possible that interventions of longer duration carry the risk of
over-sensitizing subjects to their status as cancer patients,
leading them to doubt their ability to cope without professional
support (Maguire et al, 1980). However, more data are
required on longer term outcome.
1 Three trials were common to the anxiety and depression samples and the negative
effect can be attributed to the intervention groups being considerably more distressed
at baseline (Bloom et al, 1978; Davis, 1986; Decker et al, 1992). In the other three
anxiety trials one used a post-test only design (Cumbia, 1985), one was an evaluation
of the effect of a brief telephone intervention given to subjects already receiving a
psychosocial care programme (Houts et al, 1986), and one had no features that might
obviously account for the intervention group faring worse than the controls (Hurst,
1986).Anxiety and depression in cancer patients 1779
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SUMMARY
Main effects
A main effect of 0.36 for anxiety can be taken to be of moderate
clinical significance, this estimate is robust for a number of
factors. The main effect for depression is not robust, taking this
into account renders it clinically weak to negligible at 0.19–0.21.
Clinical and service implications
Clinically strong and cost-effective outcomes are likely to result
from interventions targeted at those suffering from or at risk of
significant psychological distress. However, more data are needed
to confirm this suggestion. Group interventions, particularly
psycho-educational courses, are at least as effective as individual.
If this finding can be replicated in Europe then group interventions
should prove considerably more cost effective than individual
(Fawzy et al, 1996).
Research implications
Routine use of randomization and samples large enough to provide
adequate statistical power will improve the reliability of future
trial data. We now have adequate estimates of the overall magni-
tude of effect of psychological interventions on anxiety and
depression in oncology. Consequently, future research would be
best directed to specific questions, the analyses suggest current
priorities as being establishing:
a. the effectiveness of interventions targeted at those at risk of, or
suffering significant distress.
b. the viability and effectiveness of group therapy in European
oncology settings.
c. whether the large effects associated with group psycho-educa-
tional courses can be replicated.
d. whether positive effects are maintained at long-term follow-
up.
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